Catalyst Wire Dossier Catalyst Wire Dossier

Elidel 1%

pimecrolimus · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elidel 1%, covering 2011-04-15 to 2011-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis [Phase 4]

See pricing